![]() |
Chem 162/262 |
![]() |
Dr. Kalju Kahn
Office: PSB-N 1511
Office hours: Tue and Fri (12:00-1:00 PM) or by appointment
Phone: 893-6157
E-mail: kalju@chem.ucsb.edu
Website: http;//www.chem.ucsb.edu
August Estabrook Office hours: Chem 1148, Phone: 893-8283 E-mail: aestabrook@chem.ucsb.edu
To teach principles that govern the process of modern drug discovery and development. Students in the course follow a path similar to that taken by real-life drug developers by learning important elements of the drug design process in a logical order.
Lecture: MWF 10:00-10:50 Place: Webb 1100
Computer Lab: Open access Place: Chem 1153
| Syllabus | General information about the course. | |
| Textbook | The Organic Chemistry of Drug Design and Drug Action by Richard B. Silverman (Second Edition) | $80 (Amazon) |
| Sample Lecture | Target Validation. (No Password Needed) Warning: Large File | PDF WAV |
| Year 2003 | Drug Desing (by Dr. Norbert Reich) website for Spring 2003 | Link |
| Upload | Submit your assignments as MS Word or PDF files | Link |
| Exam | Exam Preparation Guide | |
| Exam | Sample questions from my last year Chem 112L test | |
| Exam Key | Sample answers to some questions in the exam |
Course notes will be posted here before 7:30 a.m. of the lecture day. These files are password-protected. Contact your instructor to obtain the password.
| Notes | Powerpoint Lecture Note Pages in PDF | Acrobat |
| March 29 | Overview of the course. History of drug design | |
| March 31 | Current trends and future of drug design. Diseases | |
| April 2 | Target Validation | |
| April 5 | Target Validation | |
| April 7 | Enzymes and Receptors | |
| April 9 | Receptors, Lead Identification, Interactions | |
| April 12 | Lead Modifications | |
| April 14 | Pharmacokinetics | |
| April 16 | Enzyme Mechanisms | |
| April 19 | Enzyme Kinetics | |
| April 21 | Enzyme Inhibition | |
| April 23 | Enzyme Inactivation; Receptor Studies | |
| April 26 | Displacement Assay; Structure-Based Drug Design | |
| April 28 | Structure-Based Drug Design: Principles | |
| April 30 | Structure-Based Drug Design: Docking and Visualization | |
| May 3 | Structure-Based Drug Design: Free Energy Simulations | |
| May 5 | Combinatorial Chemistry | |
| May 10 | QSAR | |
| May 12 | Drug Metabolism | |
| May 14 | Drug Metabolism | |
| May 17 | Prodrugs and Drug Delivery | |
| May 19 | Pharmacogenomics | |
| May 21 | Pharmacogenomics | |
| May 24 | Nucleic Acid Drugs | |
| June 2 | Pharmaceutical Industry: Jobs, Trends, and Outlook |
| Literature | Required reading in PDF | Acrobat |
| General | From Serendipity to Rational Drug Design | |
| History | Drug Discovery: A Historical Perspective | |
| Future | Drug Research: Myths, Hype and Reality | |
| Future | Cell-based uHTS Chemical Genomic Drug Discovery | |
| Validation | Drug Discovery in the Post-Genomic Era | |
| Validation | DNA Microarrays | |
| Validation | mRNA Knockdown: Antisense, Ribozymes, RNAi | |
| Validation | Proteomics: Proteins Rule | |
| Validation | Single Nucleotide Polymorphisms: Review | |
| Targets | Protein Kinases | |
| Leads | HIV Protease Inhibitors | |
| ADME | Predicting Pharmacokinetics | |
| Enzymes | Transition State Binding | |
| SBDD | The Process of Structure-Based Drug Design | |
| SBDD | High-throughput docking | |
| SBDD | Nicotinic Acetylcholine Receptor: Docking | |
| Pharmacogenomics | Better Therapeutics through Microarrays | |
| Gene Therapy | X-Linked SCID: Gene Therapy and Leukemia | |
| Antisense Therapy | Novel Antisense and PNA Strategies | |
| Protein Therapy | Preclinical safety of Biopharmaceuticals | |
| Protein Therapy | Glycoengineering |
Suggested literature can be found now on a separate page
The assignments are posted one week before the due date. Answers shall be submitted electronically no later than the midnight of the due date.
| Assignments | Acrobat | |
| 0 | Drug Design Proposal Tips. | |
| 1 | Target Validation | |
| 2 | Biomolecular Interactions. Pharmacokinetics. Receptors and Enzymes. | |
| 2 | Question 2C Inhibitor Structure. | ![]() |
| 3 | Enzyme Mechanisms. | |
| 4 | Enzyme Inhibition and Inactivation. | |
| 5 | Structure-Based Drug Design. | |
| 6 | QSAR. | |
| 7 | Drug Metabolism and Prodrugs. | |
| 8 | Gene Therpay, Protein Drugs, Intellectual Property. |
The assignment keys are typically posted one week after the due date.
| Keys | Acrobat | |
| 1 | Target Validation | |
| 2 | Biomolecular Interactions. Pharmacokinetics. Receptors and Enzymes. | |
| 3 | Enzyme Mechanisms. | |
| 4 | Enzyme Inhibition and Inactivation. | |
| 5 | Structure-Based Drug Design. | |
| 6 | QSAR. | |
| 7 | Drug Metabolism and Prodrugs. | |
| 8 | Gene Therpay, Protein Drugs, Intellectual Property. |
Students in this course encounter many terms which have specific meaning in the context of drug design and medicine. You may find our glossary helpful when reading some of the assigned papers. If you encounter a term that is not in this dictionary, you could try a specialized medicinal chemistry glossary at www.chem.qmw.ac.uk/iupac/medchem ,an on-line dictionary at www.dictionary.com or an on-line encyclopedia at www.wikipedia.com . Feel free to send any additions and suggestions to Kalju Kahn
PyMOL Home Page
Biomolecular Images for Teaching with PyMOL
SYBYL Tutorial
Short List of Programs
Modern Drug Discovery
Nature Reviews Drug Discovery
Drug Discovery and Development
Drug Design Lecture Notes by Dr. Hugo Kubinyi
Oxford Drug Resistance Group Lectures
Basic Pharmacokinetics
Calcium Channel Blockers
Brain Chemistry
Acetylcholine Receptor
Online Video-Lectures
Dr. Andrew Boa lecture notes
An Overview of Marine Drug Discovery
Electronic Journals at UCSB
Google Web Search Engine
Biology Workbench
ExPASy Molecular Biology Server
Protein Data Bank
Periodic Table of the Elements
Cell and Molecular Biology Protocols Online
UCSB General Catalog
UCSB Campus Map
UCSB Gold Login
UCSB Umail Access
UCSB Environmental Health and Safety